Is Outlook Therapeutics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: OTLK) stock is to Strong Buy OTLK stock.
Out of 3 analysts, 2 (66.67%) are recommending OTLK as a Strong Buy, 1 (33.33%) are recommending OTLK as a Buy, 0 (0%) are recommending OTLK as a Hold, 0 (0%) are recommending OTLK as a Sell, and 0 (0%) are recommending OTLK as a Strong Sell.
According to 3 Wall Street analysts that have issued a 1 year OTLK price target, the average OTLK price target is $5.33, with the highest OTLK stock price forecast at $7.00 and the lowest OTLK stock price forecast at $4.00.
On average, Wall Street analysts predict that Outlook Therapeutics's share price could reach $5.33 by Feb 15, 2024. The average Outlook Therapeutics stock price prediction forecasts a potential upside of 389.27% from the current OTLK share price of $1.09.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.